Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05472636
Other study ID # 97
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 11, 2022
Est. completion date June 1, 2022

Study information

Verified date July 2022
Source Istanbul Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

INTRODUCTION: Granuloma annulare is a non-infectious, granulomatous disease that can affect children and adults. Although there are many studies examining adult patients, there are limited studies examining pediatric granuloma annulare cases. It is aimed to examine the demographic, clinical, and pathological features of pediatric granuloma annulare cases in this study. MATERIALS and METHODS: This study was performed retrospectively in a single-center, tertiary dermatology hospital. Forty-one patients, under the age of 18 who were admitted to the dermatology outpatient clinic between 2008-2021 and diagnosed with granuloma annulare were scanned from the hospital database and patient photograph archive. Demographic characteristics, and clinical and histopathological features were evaluated.


Description:

Granuloma annulare; is a non-infectious, granulomatous skin reaction with potential triggers that can affect the adult and pediatric age group. Diabetes mellitus, hyperlipidemia, and malignancy have been described in association with adult granuloma annulare cases. While there are studies on the clinical, pathological features and associated diseases in patients with adult granuloma annulare, a limited number of studies have been conducted on pediatric granuloma annulare patients. Therefore, clinical and histopathological evaluation of pediatric granuloma annulare cases was planned in our study. This study was performed retrospectively in a single-center tertiary dermatology hospital. Patients under the age of 18 who were admitted to the dermatology outpatient clinic between 2008-2021 and diagnosed with granuloma annulare were scanned from the hospital database and patient photograph archive. Cases with uncertain diagnosis were not included in the study. Cases with dermatological findings recorded in detail and/or diagnosed histopathologically were included in the study. Demographic features, lesion localization, lesion characteristics (size, elementary lesion, color), involvement (localized/generalized), histopathological features, concomitant diseases, differential diagnoses in cases with histopathology, regression time and recommended treatments were recorded.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date June 1, 2022
Est. primary completion date May 11, 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Being under 18 years old - Having granuloma annulare - Applying to the Istanbul Training and Research Hospital, Dermatology Outpatient Clinic between 2008-2021 - Consenting to participate in the study Exclusion Criteria: -Being over 18 years old

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Istanbul Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the genders of the pediatric patients with granuloma annulare male, female day 0
Primary Evaluation of the ages of the pediatric patients with granuloma annulare age (year) day 0
Primary Evaluation of the concomitant diseases of the pediatric patients with granuloma annulare the concomitant diseases of the participants day 0
Primary Evaluation of the lesion localization of the pediatric patients with granuloma annulare head and neck, upper extremity, lower extremity, trunk day 0
Primary Evaluation of the lesion duration of the pediatric patients with granuloma annulare the time interval in between appearance of the lesion and diagnosis (month) day 0
Primary Evaluation of the lesion type of the pediatric patients with granuloma annulare papule, pustule, plaque, nodule day 0
Primary Evaluation of the mean size of the lesion diameter (cm) day 0
Primary Evaluation of the clinical involvement localized, generalized day 0
Primary Histopathological evaluation of the infiltration type of the pediatric patients with granuloma annulare neutrophilic, lymphocytic, lymphohistiocytic, eosinophil, mixed infiltrations day 0
Primary Histopathological evaluation of the infiltration pattern of the pediatric patients with granuloma annulare Interstitial, palisadic day 0
Primary Evaluation of epidermal findings regular/irregular, hyperkeratosis, acanthosis day 0
Primary Evaluation of depth of infiltrate superficial, medium, deep day 0
See also
  Status Clinical Trial Phase
Recruiting NCT05580042 - Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare Phase 1
Active, not recruiting NCT05650736 - Janus Kinase Inhibition in Granuloma Annulare Phase 2
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Completed NCT00720980 - Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
Terminated NCT00476697 - UVA1 Light for Scleroderma and Similar Conditions N/A
Completed NCT00129428 - Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix Phase 1/Phase 2
Completed NCT03910543 - Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Phase 1